- Home
- CMTL vs FGEN Comparison
CMTL vs FGEN Comparison
Compare CMTL & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- FGEN
- Stock Information
- Founded
- CMTL 1967
- FGEN 1993
- Country
- CMTL United States
- FGEN United States
- Employees
- CMTL N/A
- FGEN N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- FGEN Health Care
- Exchange
- CMTL Nasdaq
- FGEN Nasdaq
- Market Cap
- CMTL 41.7M
- FGEN 33.5M
- IPO Year
- CMTL N/A
- FGEN 2014
- Fundamental
- Price
- CMTL $1.57
- FGEN $0.29
- Analyst Decision
- CMTL Strong Buy
- FGEN Strong Buy
- Analyst Count
- CMTL 1
- FGEN 1
- Target Price
- CMTL $9.25
- FGEN $10.00
- AVG Volume (30 Days)
- CMTL 145.7K
- FGEN 594.8K
- Earning Date
- CMTL 06-17-2025
- FGEN 05-12-2025
- Dividend Yield
- CMTL N/A
- FGEN N/A
- EPS Growth
- CMTL N/A
- FGEN N/A
- EPS
- CMTL N/A
- FGEN N/A
- Revenue
- CMTL $496,641,000.00
- FGEN $6,996,000.00
- Revenue This Year
- CMTL N/A
- FGEN $232.81
- Revenue Next Year
- CMTL $4.14
- FGEN $9.16
- P/E Ratio
- CMTL N/A
- FGEN N/A
- Revenue Growth
- CMTL N/A
- FGEN N/A
- 52 Week Low
- CMTL $1.19
- FGEN $0.18
- 52 Week High
- CMTL $5.16
- FGEN $1.74
- Technical
- Relative Strength Index (RSI)
- CMTL 51.47
- FGEN 44.68
- Support Level
- CMTL $1.36
- FGEN $0.29
- Resistance Level
- CMTL $1.71
- FGEN $0.32
- Average True Range (ATR)
- CMTL 0.10
- FGEN 0.02
- MACD
- CMTL 0.03
- FGEN 0.00
- Stochastic Oscillator
- CMTL 51.28
- FGEN 25.83
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.